Kinnate Biopharma, Inc. (KNTE)

NASDAQ: KNTE · IEX Real-Time Price · USD
12.62
-0.38 (-2.92%)
Jun 29, 2022 4:00 PM EDT - Market closed

Total Valuation

KNTE has a market cap or net worth of $555.00 million. The enterprise value is $288.96 million.

Market Cap 555.00M
Enterprise Value 288.96M

Important Dates

The next earnings date is Monday, August 15, 2022, before market open.

Estimated Earnings Date Aug 15, 2022
Ex-Dividend Date n/a

Share Statistics

KNTE has 43.98 million shares outstanding. The number of shares has increased by 0.93% in one year.

Shares Outstanding 43.98M
Shares Change (YoY) +0.93%
Shares Change (QoQ) +0.36%
Owned by Insiders (%) 0.25%
Owned by Institutions (%) 94.28%
Float 15.73M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 1.88
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 20.15, with a Debt / Equity ratio of 0.02.

Current Ratio 20.15
Quick Ratio 19.82
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -30.10%, which is considered low. The company has a ROIC of -43.40%.

Return on Equity (ROE) -30.10%
Return on Assets (ROA) -26.30%
Return on Capital (ROIC) -43.40%
Revenue Per Employee n/a
Profits Per Employee -$1.46M
Employee Count 68
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -46.73% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change -46.73%
50-Day Moving Average 9.40
200-Day Moving Average 10.87
Average Volume (30 Days) 185,800

Short Selling Information

The latest short interest is 2.74 million, so 6.23% of the outstanding shares have been sold short.

Short Interest 2.74M
Short % of Shares Out 6.23%
Short % of Float 17.43%
Short Ratio (days to cover) 14.50

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -99.69M
Net Income -99.21M
EBITDA -99.06M
EBIT -99.21M
Earnings Per Share (EPS) -$2.27
Full Income Statement

Balance Sheet

The company has $270.63 million in cash and $4.60 million in debt, giving a net cash position of $266.04 million or $6.05 per share.

Cash & Cash Equivalents 270.63M
Total Debt 4.60M
Net Cash 266.04M
Net Cash Per Share $6.05
Book Value 295.82M
Book Value Per Share 6.73
Working Capital 261.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$78.71 million and capital expenditures -$2.78 million, giving a free cash flow of -$81.49 million.

Operating Cash Flow -78.71M
Capital Expenditures -2.78M
Free Cash Flow -81.49M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

KNTE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -17.88%
FCF Yield -14.68%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -0.93%
Shareholder Yield -0.93%
Dividend Details

Analyst Forecast

The average price target for KNTE is $35.02, which is 177.50% higher than the current price. The consensus rating is "Buy".

Price Target $35.02
Price Target Difference 177.50%
Analyst Consensus Buy
Analyst Count 13
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a